Galena Biopharma rallies, SA bull upbeat for 2014

|About: Galena Biopharma, Inc. (GALE)|By:, SA News Editor

Shares of Galena Biopharma (GALE +3.9%) are enjoying a strong session.

SA contributor and long-time bull Regarded Solutions is out reiterating a positive outlook for the company going into the new year.

"GALE should continue to deliver positive results as they proceed in Phase 3 trials of [their] potential legacy drug, NeuVax," the author says, adding that "sales of Abstral could surprise everyone."